Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8232417 | International Journal of Radiation Oncology*Biology*Physics | 2010 | 8 Pages |
Abstract
The addition of neoadjuvant chemotherapy to local-field radiotherapy reduced central nervous system cancer recurrence when high-risk patients were excluded by thorough pretreatment staging. There was trend toward improved central nervous system tumor control when larger fields (whole brain, whole ventricle, or craniospinal axis) were used.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Ashley W. M.D., Nadia N. M.D., Jan C. M.D., Paula J. M.D., Cynthia J. M.D., Ph.D., Paul D. M.D.,